Wall Street Journal, November 30, 2016. Negotiators still need to hammer out agreement in some areas, including GOP proposals for limiting FDA regulation.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
A Frenzy of Lobbying on 21st Century Cures
Kaiser Health News, November 28, 2016. Beyond the pharmaceutical industry, the bill’s supporters include universities, medical schools and groups representing them, as well as patient groups funded by drug and device companies. “It really is a David and Goliath issue of where the money is,” NCHR president Diana Zuckerman said.
Read More »Consumer Groups Caution Dems on ‘Cures’ Bill
The Hill, November 28, 2016. NCHR president Diana Zuckerman said the bill “makes it much easier to get FDA approval for things that may not work and may not be safe.”
Read More »Conservative and Progressive Experts Join Forces to Expose Under-the-Radar Consequences of 21st Century Cures Act
PR Newswire, November 22, 2016. Experts from opposite ends of the ideological spectrum were united over concern about the 21st Century Cures Act at an emergency briefing in the U.S. Senate yesterday. While highlighting different problems, they agreed that Congress should not rush a closed-door negotiated version of the bill during the lame-duck session.
Read More »Law Firm that Believes FDA is ‘Broken’ Highlights Cures Act Fears
Fierce Biotech, November 23, 2016. We know it’s a top priority for Congress, but a group of panelists speaking at an “emergency briefing” in the U.S. Senate this week hosted by an anti-FDA legal co have urged lawmakers to not “rush a closed-door negotiated version of the bill during the lame-duck session.”
Read More »